Published in J Control Release on September 11, 2013
Recent In Vivo Evidences of Particle-Based Delivery of Small-Interfering RNA (siRNA) into Solid Tumors. J Pharm Innov (2014) 0.89
AEG-1 promoter-mediated imaging of prostate cancer. Cancer Res (2014) 0.86
Exploiting base excision repair to improve therapeutic approaches for pancreatic cancer. Front Nutr (2015) 0.78
Ovarian cancer treatment with a tumor-targeting and gene expression-controllable lipoplex. Sci Rep (2016) 0.76
Spatial Control of Gene Expression by Nanocarriers Using Heparin Masking and Ultrasound-Targeted Microbubble Destruction. ACS Nano (2016) 0.75
Design, synthesis and evaluation of VEGF-siRNA/CRS as a novel vector for gene delivery. Drug Des Devel Ther (2016) 0.75
Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor. Oncogene (2017) 0.75
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (1998) 72.56
Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst (2004) 5.39
Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res (2002) 4.99
Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver. Hepatology (2007) 1.97
Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. Nat Med (2005) 1.93
Viral gene therapy strategies: from basic science to clinical application. J Pathol (2006) 1.88
Modulation of inflammasome pathways by bacterial and viral pathogens. J Immunol (2011) 1.85
Dendrimers in gene delivery. Adv Drug Deliv Rev (2005) 1.73
Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J Control Release (2003) 1.54
Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA. J Control Release (2009) 1.53
Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant. Cancer Gene Ther (2000) 1.47
Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther (2001) 1.47
Gene delivery by lipoplexes and polyplexes. Eur J Pharm Sci (2010) 1.45
Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells. Stem Cells (2007) 1.35
Ligand-directed retroviral targeting of human breast cancer cells. Proc Natl Acad Sci U S A (1995) 1.32
Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Bioconjug Chem (2003) 1.31
Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs. RNA (2013) 1.24
Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics. J Pharm Sci (2011) 1.24
Novel polyethylenimine-derived nanoparticles for in vivo gene delivery. Expert Opin Drug Deliv (2012) 1.16
Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies. Int J Pharm (2011) 1.13
RNA interference therapeutics for cancer: challenges and opportunities (review). Mol Med Rep (2012) 1.11
CD95L/FasL and TRAIL in tumour surveillance and cancer therapy. Cancer Treat Res (2006) 1.10
Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy. J Gene Med (2009) 1.10
In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection. Int J Nanomedicine (2010) 1.09
In vivo comparative study of lipid/DNA complexes with different in vitro serum stability: effects on biodistribution and tumor accumulation. J Pharm Sci (2008) 1.08
Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy. Mol Ther (2012) 1.07
NF-κB activity regulates mesenchymal stem cell accumulation at tumor sites. Cancer Res (2012) 1.06
Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice. Hepatology (2002) 1.04
Stem cell based cancer gene therapy. Mol Pharm (2011) 1.04
Review: novel nonviral delivery approaches for interleukin-12 protein and gene systems: curbing toxicity and enhancing adjuvant activity. J Interferon Cytokine Res (2006) 1.02
Murine bone marrow-derived mesenchymal stem cells as vehicles for interleukin-12 gene delivery into Ewing sarcoma tumors. Cancer (2009) 1.01
Mesenchymal stem cells as a gene therapy carrier for treatment of fibrosarcoma. Cytotherapy (2009) 0.99
Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice. Hepatology (2011) 0.99
Lipid encapsulation enables the effective systemic delivery of polyplex plasmid DNA. Mol Ther (2007) 0.99
Stem cells as vectors to deliver HSV/tk gene therapy for malignant gliomas. Curr Stem Cell Res Ther (2009) 0.98
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors. Cancer Res (2005) 0.96
Tumor-specific gene delivery using recombinant vaccinia virus in a rabbit model of liver metastases. J Natl Cancer Inst (1999) 0.96
Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery. J Control Release (2010) 0.96
A review of the current status of siRNA nanomedicines in the treatment of cancer. Biomaterials (2013) 0.95
Tumor-specific gene transfer with receptor-mediated nanocomplexes modified by polyethylene glycol shielding and endosomally cleavable lipid and peptide linkers. FASEB J (2010) 0.95
The therapeutic potential of TRAIL receptor signalling in cancer cells. Clin Transl Oncol (2011) 0.95
Small RNAs and non-small cell lung cancer. Curr Mol Med (2006) 0.95
Cationic lipids activate intracellular signaling pathways. Adv Drug Deliv Rev (2012) 0.94
EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma. Biomaterials (2011) 0.93
Cancer-specific transgene expression mediated by systemic injection of nanoparticles. Cancer Res (2009) 0.92
Insulin-like growth factor-binding protein-7 (IGFBP7): a promising gene therapeutic for hepatocellular carcinoma (HCC). Mol Ther (2013) 0.92
Integrin-targeted nanocomplexes for tumour specific delivery and therapy by systemic administration. Biomaterials (2010) 0.92
Oligoethylenimine-grafted polypropylenimine dendrimers as degradable and biocompatible synthetic vectors for gene delivery. J Control Release (2008) 0.89
Phase I study of liposome-DNA complexes encoding the interleukin-2 gene in dogs with osteosarcoma lung metastases. Hum Gene Ther (2005) 0.89
Targeting gene therapy for prostate cancer cells by liposomes complexed with anti-prostate-specific membrane antigen monoclonal antibody. Hum Gene Ther (2006) 0.88
Nanoparticle-mediated interleukin-12 cancer gene therapy. J Pharm Pharm Sci (2010) 0.87
Systemic delivery of (gamma1)34.5-deleted herpes simplex virus-1 selectively targets and treats distant human xenograft tumors that express high MEK activity. Cancer Res (2007) 0.87
Stabilized integrin-targeting ternary LPD (lipopolyplex) vectors for gene delivery designed to disassemble within the target cell. Bioconjug Chem (2009) 0.87
The biological routes of gene delivery mediated by lipid-based non-viral vectors. Expert Opin Drug Deliv (2009) 0.86
Construction of a star-shaped copolymer as a vector for FGF receptor-mediated gene delivery in vitro and in vivo. Biomacromolecules (2010) 0.86
Tumor-targeted delivery of biologically active TRAIL protein. Cancer Gene Ther (2010) 0.85
Suppression of pancreatic tumor progression by systemic delivery of a pancreatic-cancer-specific promoter driven Bik mutant. Cancer Lett (2005) 0.85
Efficacy of adenovirally expressed soluble TRAIL in human glioma organotypic slice culture and glioma xenografts. Cell Death Dis (2011) 0.84
Advances in viral-vector systemic cytokine gene therapy against cancer. Vaccine (2010) 0.84
Local gene delivery for cancer therapy. Curr Gene Ther (2011) 0.84
Toward a siRNA-containing nanoparticle targeted to breast cancer cells and the tumor microenvironment. Int J Pharm (2012) 0.84
Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus. Cancer Res (1999) 0.84
PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer. Biomaterials (2013) 0.84
Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effect. Gene Ther (2009) 0.84
A significant enhancement of therapeutic effect against hepatic metastases of M5076 in mice by a liposomal interleukin-2 (mixture). J Control Release (2002) 0.83
The emerging fields of suicide gene therapy and virotherapy. Trends Mol Med (2002) 0.83
Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases. Ann Surg (1999) 0.81
Aerosol delivery of beclin1 enhanced the anti-tumor effect of radiation in the lungs of K-rasLA1 mice. J Radiat Res (2012) 0.81
Antitumor effect of murine dendritic and tumor cells transduced with IL-2 gene. Folia Histochem Cytobiol (2012) 0.79
Re: Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst (2005) 0.78
Growth inhibition of the pulmonary metastatic tumors by systemic delivery of the p27 kip1 gene using lyophilized lipid-polycation-DNA complexes. J Gene Med (2009) 0.78
Web and database software for identification of intact proteins using "top down" mass spectrometry. Anal Chem (2003) 1.85
The role of lipid charge density in the serum stability of cationic lipid/DNA complexes. Biochim Biophys Acta (2004) 1.08
Medulloblastoma exosome proteomics yield functional roles for extracellular vesicles. PLoS One (2012) 1.08
In vivo comparative study of lipid/DNA complexes with different in vitro serum stability: effects on biodistribution and tumor accumulation. J Pharm Sci (2008) 1.08
The stability of lyophilized lipid/DNA complexes during prolonged storage. J Pharm Sci (2004) 1.03
Cholesterol domains in cationic lipid/DNA complexes improve transfection. Biochim Biophys Acta (2008) 1.00
Effect of cholesterol nanodomains on the targeting of lipid-based gene delivery in cultured cells. Mol Pharm (2010) 0.95
Metal contaminants promote degradation of lipid/DNA complexes during lyophilization. Biochim Biophys Acta (2006) 0.92
Contribution of hydrophobicity to thermodynamics of ligand-DNA binding and DNA collapse. Biophys J (2005) 0.91
Surface functionalization of exosomes using click chemistry. Bioconjug Chem (2014) 0.90
The effect of cholesterol domains on PEGylated liposomal gene delivery in vitro. Ther Deliv (2011) 0.89
The use of fluorescence resonance energy transfer to monitor dynamic changes of lipid-DNA interactions during lipoplex formation. Biochim Biophys Acta (2003) 0.87
Degradation kinetics of high molecular weight poly(L-lactide) microspheres and release mechanism of lipid:DNA complexes. J Pharm Sci (2004) 0.87
Targeting Her-2+ breast cancer cells with bleomycin immunoliposomes linked to LLO. Mol Pharm (2012) 0.85
Effects of PEGylation on the preservation of cationic lipid/DNA complexes during freeze-thawing and lyophilization. J Pharm Sci (2002) 0.84
Ligands located within a cholesterol domain enhance gene delivery to the target tissue. J Control Release (2012) 0.83
Degradation of lyophilized lipid/DNA complexes during storage: the role of lipid and reactive oxygen species. Biochim Biophys Acta (2008) 0.83
Effect of glycine on pH changes and protein stability during freeze-thawing in phosphate buffer systems. J Pharm Sci (2002) 0.83
Cholesterol domains enhance transfection. Ther Deliv (2013) 0.83
Formulation strategies to minimize oxidative damage in lyophilized lipid/DNA complexes during storage. J Pharm Sci (2008) 0.83
Immobilization of nonviral vectors during the freezing step of lyophilization. J Pharm Sci (2004) 0.82
Formulation development of freeze-dried oligonucleotide-loaded gelatin nanoparticles. Eur J Pharm Biopharm (2008) 0.81
An infrared spectroscopic study of the effect of hydration on cationic lipid/DNA complexes. J Pharm Sci (2003) 0.81
Understanding the performance and impact of public knowledge translation funding interventions: protocol for an evaluation of Canadian Institutes of Health Research knowledge translation funding programs. Implement Sci (2012) 0.81
Rationale for the selection of an aerosol delivery system for gene delivery. J Aerosol Med (2006) 0.80
Functional characterization of the ferroxidase, permease high-affinity iron transport complex from Candida albicans. Mol Microbiol (2011) 0.80
Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions. ACS Nano (2017) 0.79
Synergistic effects of surfactants and sugars on lipoplex stability during freeze-drying and rehydration. J Pharm Sci (2009) 0.79
Effects of moisture content on the storage stability of dried lipoplex formulations. J Pharm Sci (2009) 0.78
Ability of spermine to differentiate between DNA sequences--preferential stabilization of A-tracts. Biophys Chem (2006) 0.78
The effects of lipoplex formulation variables on the protein corona and comparisons with in vitro transfection efficiency. J Control Release (2013) 0.76
Relating toxicity to transfection: using sphingosine to maintain prolonged expression in vitro. Mol Pharm (2014) 0.75
An initial animal proof-of-concept study for central administration of clozapine to schizophrenia patients. Schizophr Res (2008) 0.75
Long-term storage of lyophilized liposomal formulations. J Pharm Sci (2014) 0.75
Moisture content impacts the stability of DNA adsorbed onto gold microparticles. J Pharm Sci (2011) 0.75
DNA hydrodynamic degradation controlled by Kolomogorov length scales in pipe flow. J Pharm Sci (2011) 0.75
Application of a ultra performance liquid chromatography method in the determination of DNA quality and stability. J Pharm Sci (2011) 0.75